Literature DB >> 511978

Origin of estrogen in normal men and in women with testicular feminization.

P C MacDonald, J D Madden, P F Brenner, J D Wilson, P K Siiteri.   

Abstract

The purpose of this study was to quantify the various sources of estrone (E1) and 17 beta-estradiol (E2) production in normal men and in women with testicular feminization. The mean production rate of E1 in four young adult men was 58 micrograms/24 h, while that of E2 was 44 micrograms/24 h. In these men, E1 production could be accounted for totally by extraglandular formation through 1) aromatization of plasma androstenedione, 2) conversion of E2 which was formed from the aromatization of plasma testosterone, and 3) conversion of secreted E2. In these men, only 12 micrograms or less of E2 production could not be accounted for by extraglandular formation from plasma C19 precursors, and is presumed to have arisen by testicular secretion. In six women with testicular feminization, the mean production rate of E1 was 99 micrograms/24 h, while that of E2 was 77 micrograms/24 h. THe amount of E2 production that arose by glandular secretion could be computed in four of these women and was considerably greater than that found in the young adult men. In these women with testicular feminization, an average of 44 micrograms/24 h E2 could not be accounted for by extraglandular formation and is presumed to have arisen by testicular secretion. The mean plasma production rate of testosterone in the normal men was 5.7 mg/24 h, while that in the women with testicular feminization was 8.3 mg/24 h. However, the range of plasma production rates of testosterone in the women with testicular feminization was large (1.3--17.0 mg/24 h).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 511978     DOI: 10.1210/jcem-49-6-905

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Gonadal steroids and body composition, strength, and sexual function in men.

Authors:  Joel S Finkelstein; Hang Lee; Sherri-Ann M Burnett-Bowie; J Carl Pallais; Elaine W Yu; Lawrence F Borges; Brent F Jones; Christopher V Barry; Kendra E Wulczyn; Bijoy J Thomas; Benjamin Z Leder
Journal:  N Engl J Med       Date:  2013-09-12       Impact factor: 91.245

Review 2.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Evaluation of breast enlargement in young males and factors associated with gynecomastia and pseudogynecomastia.

Authors:  M Yazici; M Sahin; E Bolu; D E Gok; A Taslipinar; S Tapan; D Torun; G Uckaya; M Kutlu
Journal:  Ir J Med Sci       Date:  2009-06-04       Impact factor: 1.568

4.  Association between endogenous sex steroid hormones and inflammatory biomarkers in US men.

Authors:  K K Tsilidis; S Rohrmann; K A McGlynn; S J Nyante; D S Lopez; G Bradwin; M Feinleib; C E Joshu; N Kanarek; W G Nelson; E Selvin; E A Platz
Journal:  Andrology       Date:  2013-09-30       Impact factor: 3.842

5.  Gonadal steroid-dependent effects on bone turnover and bone mineral density in men.

Authors:  Joel S Finkelstein; Hang Lee; Benjamin Z Leder; Sherri-Ann M Burnett-Bowie; David W Goldstein; Christopher W Hahn; Sarah C Hirsch; Alex Linker; Nicholas Perros; Andrew B Servais; Alexander P Taylor; Matthew L Webb; Jonathan M Youngner; Elaine W Yu
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

6.  [Hormonal principles in normal and pathologic somatic sexual development].

Authors:  H U Schweikert; F Neumann
Journal:  Klin Wochenschr       Date:  1986-01-15

7.  17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium.

Authors:  M L Casey; P C MacDonald; S Andersson
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene.

Authors:  D L S Danilovic; P H S Correa; E M F Costa; K F S Melo; B B Mendonca; I J P Arnhold
Journal:  Osteoporos Int       Date:  2006-11-01       Impact factor: 4.507

Review 9.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  The androgen resistance syndromes: clinical and biochemical aspects.

Authors:  H U Schweikert
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.